Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +8.50p +0.25% 3,461.00p 3,462.50p 3,464.00p 3,529.00p 3,458.00p 3,489.50p 3,825,018 16:35:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 9,229.1 393.7 34.8 111.5 31,480.64

Shire Share Discussion Threads

Showing 3001 to 3025 of 3025 messages
Chat Pages: 121  120  119  118  117  116  115  114  113  112  111  110  Older
DateSubjectAuthorDiscuss
19/1/2018
15:00
Should be going up as £ is weakening.
philanderer
19/1/2018
14:43
Volume has certainly picked up, the price is up and down around the 3500p mark like a yoyo right now.
romeike
19/1/2018
14:24
Will our american friends take it down yet again ?
philanderer
19/1/2018
12:19
A few closes over 3500p (support) would be encouraging
ny boy
19/1/2018
10:23
I think hefty debt loads are par for the course right now, companies have taken advantage of ultra low rates and most are now looking to reduce those debts. Shire is doing a good job of paying down debt at the moment. I'd be more concerned about the debt if it was being ignored.
romeike
19/1/2018
08:48
Reacting well to 3420p support, hopefully the bottom is in, defensive play with some upside will suit me, not really bothered about the divi, just parking some cash for a few years.
ny boy
19/1/2018
06:06
Yield 0.71% so no good for income investors, perhaps write down coming for Bax division? Is that why shareprice falling?
montyhedge
18/1/2018
15:08
Rome, had a scan of the sector over the last few days. Allergan has a hefty debt load, however owning Botox and Juvederm helps the cashflow!. They also developed Coolsculpt, which appears popular atm. Insider buying in the open market recently - I don't hold currently.
essentialinvestor
18/1/2018
14:19
EI - funny you say that, I also suspect PFE will approach AGN. M & A activity is likely to increase after a long lull especially if there is more cash floating around. Shire looking more stable into the afternoon, hope it holds now.
romeike
18/1/2018
13:24
15% drop in 3 weeks
superman21
18/1/2018
13:03
PFE will come back for AGN imv. SAN beginning to look interesting, another 4-5% lower might have a few.
essentialinvestor
18/1/2018
13:02
Support gone?
mbmiah
18/1/2018
12:29
Why is this still falling? Because of revised revenue to 17-18bn? Or some of the big guys like Pfizer not looking to buy?
superman21
18/1/2018
11:06
Quite apart from issues specific to Shire,the sector is suffering from to accelerating trend in the USA to cut health care costs by punitive action re drug costs.Hilary was bad but Trump might be worse,either way,there seems to be a consensus in the USA which could keep pharmas under a cloud.Shire's cheap but could well stay cheap in such an environment.Long term a buy.
steeplejack
18/1/2018
10:45
Bagged a few at 3421p, surprised to see it this low but buying into weakness at Shire has always worked out well in the past. Does seem entirely sentiment driven and at some point fundamentals will force a restore to a fairer value. Is this big players punishing the board for not pushing ahead with a split in Q1? If it follows a similar pattern as yesterday we can expect a revisit of the 3420p level later today so punter who missed the low this morning will likely get another chance I think. Update - picked up more at 3417p
romeike
18/1/2018
10:33
Bought close to support 3420p, too good too miss at these levels, ex divi in March, put into the ISA
ny boy
18/1/2018
09:57
EI - you may well be correct given the continued fall this morning, though I still believe that the low share prices of certain pharma stocks at the moment represent a bargain opportunity for patient investors. Now looking at two significant declines over two days on no news as part of a general decline since the start of the year with almost every day showing a drop.
romeike
18/1/2018
09:53
18th jan Liberum hold tp 4000p cut from 4100p
philanderer
18/1/2018
09:23
Rome, I tend to look at a valuation that includes net debt, which is approx 50 Billion. FCF is the metric to focus on imv. If current FCF can be maintained around these levels, Shire look cheap to me, the market may be suggesting some doubt on that.
essentialinvestor
17/1/2018
18:31
Do you think Shire is maybe worth less than £30bn, if not they you are maybe buying at the bottom of a multi year trading range into a share that could quite reasonably increase 50% from its current position.
romeike
17/1/2018
16:50
Have to say was very tempted today but just could not bring myself to buy, that's probably a bullish sign!.
essentialinvestor
17/1/2018
12:18
Juno Therapuetics up 50%, Celgene looking to buy
superman21
17/1/2018
12:04
superman , tend to agree , hopefully anyway :-)
philanderer
17/1/2018
10:16
Wasn't so sure about it dropping as far as 34.50 so bought a good chunk of shares at 34.92.
romeike
17/1/2018
10:13
Pfizer driving the price lower for buyout 🙂?
superman21
Chat Pages: 121  120  119  118  117  116  115  114  113  112  111  110  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180120 13:24:24